(Q40312679)

19 September 2017

title

Systemic inhibition of tumor growth by soluble Flk-1 gene therapy combined with cisplatin (English)

1 reference

19 September 2017

0 references

Wang R

1

1 reference

19 September 2017

Zhang XW

2

1 reference

19 September 2017

Wang GQ

3

1 reference

19 September 2017

Chen XC

4

1 reference

19 September 2017

Tian L

5

1 reference

19 September 2017

Yang HS

6

1 reference

19 September 2017

Hu M

7

1 reference

19 September 2017

Peng F

8

1 reference

19 September 2017

Yang JL

9

1 reference

19 September 2017

He QM

10

1 reference

19 September 2017

Zhang W

11

1 reference

19 September 2017

Jiang Y

12

1 reference

19 September 2017

Deng HX

13

1 reference

19 September 2017

Wen YJ

14

1 reference

19 September 2017

Li J

15

1 reference

19 September 2017

Zhao X

16

1 reference

19 September 2017

Wei YQ

17

1 reference

19 September 2017

language of work or name

1 reference

23 June 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

13

1 reference

19 September 2017

issue

10

1 reference

19 September 2017

page(s)

940-947

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700958

19 September 2017

exact match

0 references

cites work

DNA strand breaks and apoptosis induced by oxaliplatin in cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

Mechanisms of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

The rationale and future potential of angiogenesis inhibitors in neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

The implications of angiogenesis for the biology and therapy of cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

Clinical applications of angiogenic growth factors and their inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

Vascular endothelial growth factor, a potent and selective angiogenic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

The biology of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

Wide spectrum of antitumor activity of a neutralizing monoclonal antibody to human vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

Inhibition of solid tumor growth by gene transfer of VEGF receptor-1 mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

Pax2 expression occurs in renal medullary epithelial cells in vivo and in cell culture, is osmoregulated, and promotes osmotic tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

Adenovirus-mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

Gene therapy-mediated expression by tumor cells of the angiogenesis inhibitor flk-1 results in inhibition of neuroblastoma growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

7 January 2021

Transplacental carcinogenesis by stilbestrol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

7 January 2021

Anti-angiogenesis: new concept for therapy of solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

7 January 2021

Vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

7 January 2021

Vascular endothelial growth factor (VEGF) and its receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

7 January 2021

Blockade of in vivo VEGF-mediated angiogenesis by antisense gene therapy: role of Flk-1 and Flt-1 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

7 January 2021

Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700958

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700958

1 reference

Dimensions Publication ID

19 September 2017

1029839930

0 references

1 reference